McLeod Ian 4
4 · Anika Therapeutics, Inc. · Filed Mar 17, 2026
Research Summary
AI-generated summary of this filing
Anika (ANIK) SVP Ian McLeod Receives Award, Exercises Derivatives
What Happened Ian McLeod, SVP, CAO & Treasurer of Anika Therapeutics (ANIK), received shares from vested RSUs/PSUs and conversions of derivative awards on March 14–15, 2026. In total he acquired 7,593 shares (3,774 + 1,161 + 2,658). To satisfy withholding obligations, the issuer retained 2,230 shares (1,449 on Mar 14 and 781 on Mar 15) — recorded as dispositions for tax withholding with an aggregate withholding value of $31,666 ($20,576 + $11,090). The underlying vesting/exercise entries are coded as awards (A) and derivative exercises/conversions (M); the withheld shares are coded F (tax withholding).
Key Details
- Transaction dates: March 14–15, 2026. Filing date: March 17, 2026.
- Shares acquired: 7,593 total (3,774; 1,161; 2,658).
- Shares withheld for taxes: 2,230 total (1,449 @ $14.20 = $20,576; 781 @ $14.20 = $11,090). Total withholding ≈ $31,666.
- Prices: The RSU/PSU/derivative conversions are reported with $0 exercise price (typical for vesting awards); withholding calculated at $14.20/share.
- Shares owned after the transactions: not specified in the provided excerpt of the filing.
- Footnotes of note:
- F2/F5/F6: These transactions reflect vesting installments from prior PSU/RSU grants (including performance-based PSUs granted Mar 14, 2025 and multi-year RSU grants).
- F3/F4: The 1,449 and 781 shares were retained by the issuer to satisfy tax withholding.
- Filing timeliness: Form filed Mar 17, 2026 reporting transactions on Mar 14–15; the filing does not indicate a late-report flag in the provided excerpt.
Context
- These transactions are primarily vesting/conversion events (awards and derivative conversions) rather than open-market purchases or discretionary sales. The retained shares are a routine tax-withholding action (often called a "sell-to-cover" or share retention) and do not necessarily indicate a market-directed sale by the insider.
- The PSU entry noted is performance-based and vests only upon achievement of pre-set targets; the filing indicates this was the first vesting installment for that award.
Insider Transaction Report
Form 4
McLeod Ian
SVP, CAO & Treasurer
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-03-14+3,774→ 22,518 total - Award
Common Stock
[F2]2026-03-14+1,161→ 23,679 total - Tax Payment
Common Stock
[F3]2026-03-14$14.20/sh−1,449$20,576→ 22,230 total - Exercise/Conversion
Common Stock
[F1]2026-03-15+2,658→ 24,888 total - Tax Payment
Common Stock
[F4]2026-03-15$14.20/sh−781$11,090→ 24,107 total - Exercise/Conversion
Restricted Stock Unit
[F1][F5]2026-03-14−3,774→ 7,550 total→ Common Stock (3,774 underlying) - Exercise/Conversion
Restricted Stock Unit
[F1][F6]2026-03-15−2,658→ 2,659 total→ Common Stock (2,658 underlying)
Footnotes (6)
- [F1]Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock.
- [F2]On March 14, 2025, the Reporting Person was granted 3,484 performance-based phantom RSUs ("PSUs") with vesting contingent upon the achievement of pre-established performance and strategic targets. This transaction represents the first vesting installment of such PSU award.
- [F3]Reflects an aggregate of 1,449 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs and PSUs that vested on March 14, 2026.
- [F4]Reflects an aggregate of 781 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 15, 2026.
- [F5]On March 14, 2025, the Reporting Person was granted 11,324 RSUs vesting in three equal annual installments beginning on March 14, 2026. This transaction reflects the first vesting installment of such RSU award.
- [F6]On March 15, 2024, the Reporting Person was granted 7,976 RSUs vesting in three equal annual installments beginning on March 15, 2025. This transaction reflects the second vesting installment of such RSU award.
Signature
/s/ Ian McLeod|2026-03-17